Brief évidence clinique (GRADE) — Gapup agent-payable C-suite expertise (RISK). Returns a structured, audited deliverable. Answers: Review the clinical evidence for <drug/intervention> in <indication> — GRADE rating, key trials, safety signals. · Scan safety signals for <molecule> in <population>...
Part of the Mcp Knowledge server.
Free to start. No card required.
AI agents use clinical_evidence_briefer to create or modify resources in Mcp Knowledge. Write operations carry medium risk because an autonomous agent could trigger bulk unintended modifications. Rate limits prevent a single agent session from making hundreds of changes in rapid succession. Argument validation ensures the agent passes expected values.
Without a policy, an AI agent could call clinical_evidence_briefer repeatedly, creating or modifying resources faster than any human could review. PolicyLayer's rate limiting ensures write operations happen at a controlled pace, and argument validation catches malformed or unexpected inputs before they reach Mcp Knowledge.
Write tools can modify data. A rate limit prevents runaway bulk operations from AI agents.
{
"version": "1",
"default": "deny",
"tools": {
"clinical_evidence_briefer": {
"limits": [
{
"counter": "clinical_evidence_briefer_rate",
"window": "minute",
"max": 30,
"scope": "grant"
}
]
}
}
}See the full Mcp Knowledge policy for all 271 tools.
These attack patterns abuse exactly the kind of access clinical_evidence_briefer gives an agent. Each links to the full case and the policy that stops it:
Other write tools across the catalogue. The same approach applies to each: rate-limit and validate the arguments.
Brief évidence clinique (GRADE) — Gapup agent-payable C-suite expertise (RISK). Returns a structured, audited deliverable. Answers: Review the clinical evidence for <drug/intervention> in <indication> — GRADE rating, key trials, safety signals. · Scan safety signals for <molecule> in <population> — adverse events, severity, frequency from FAERS and trial data. · Assess comparative effectiveness of <intervention> versus <comparator> for <disease> — what does the evidence show? · Is there evidence supporting drug repurposing of <molecule> for <new indication> — existing trials and GRADE quality? · What are the evidence gaps for <intervention> in <patient population> before formulary adoption? Reference case: Semaglutide 2.4mg · Chronic weight management in non-diabetic adults · GRADE high efficacy · studies found · nausea/GI signals · FDA approved · PubMed+ClinicalTrials+OpenFDA. Inputs are validated server-side — send the documented case fields.. It is categorised as a Write tool in the Mcp Knowledge MCP Server, which means it can create or modify data. Consider rate limits to prevent runaway writes.
Register the Mcp Knowledge MCP server in PolicyLayer and add a rule for clinical_evidence_briefer: allow, deny, rate-limit, or require approval. Point your MCP client at the PolicyLayer proxy URL and the rule is enforced on every call, before it reaches Mcp Knowledge. Nothing to install.
clinical_evidence_briefer is a Write tool with medium risk. Write tools should be rate-limited to prevent accidental bulk modifications.
Yes. Add a rate_limit block to the clinical_evidence_briefer rule in your PolicyLayer policy. For example, setting max: 10 and window: 60 limits the tool to 10 calls per minute. Rate limits are tracked per agent session and reset automatically.
Set action: deny in the PolicyLayer policy for clinical_evidence_briefer. The AI agent will receive a policy violation error and cannot call the tool. You can also include a reason field to explain why the tool is blocked.
clinical_evidence_briefer is provided by the Mcp Knowledge MCP server (https://mcp.gapup.io). PolicyLayer sits as a proxy in front of this server to enforce policies before tool calls reach the server.
Deterministic rules across all 271 Mcp Knowledge tools. Per-identity grants. Full audit log. Live in minutes. Nothing to install.
Free to start. No card required.
4,600+ MCP servers and 31,000+ tools scanned and risk-classified.